Cheil Bio Co., Ltd. announces an Equity Buyback for KRW 2,500 million worth of its shares.
March 10, 2017 at 01:50 am
Share
Cheil Bio Co., Ltd. (KOSDAQ:A052670) announces a share repurchase program. Under the program, the company will repurchase up to KRW 2,500 million worth of its shares pursuant to a trust contract with Mirae Asset Daewoo Securities Co., Ltd. The purpose of the share repurchase program is to improve shareholders value and to stabilize share price. The share repurchase program is valid until September 8, 2017. As of March 9, 2017, the company had no shares in treasury within scope available for dividend and had no shares in treasury through other repurchase.
Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Companyâs products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.
CHEILBIO CO., LTD. 
